CN109111467A - One kind 51/4His acridine compound of head spore and its drug combination preparation - Google Patents
One kind 51/4His acridine compound of head spore and its drug combination preparation Download PDFInfo
- Publication number
- CN109111467A CN109111467A CN201710477794.4A CN201710477794A CN109111467A CN 109111467 A CN109111467 A CN 109111467A CN 201710477794 A CN201710477794 A CN 201710477794A CN 109111467 A CN109111467 A CN 109111467A
- Authority
- CN
- China
- Prior art keywords
- cefotaxime
- acridine compound
- head spore
- water
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
The invention discloses one kind 51/4His acridine compound of head spore and its drug combination preparation, every mole of cefotaxime contain 51/4Mole of water.5 prepared by the method for the present invention1/4His acridine compound of head spore, the stability having had simultaneously meet requirement as preparation raw material.
Description
Technical field
The invention belongs to chemical engineering medicine crystallization technique fields, and in particular to one kind 51/4His acridine compound of head spore and
Its drug combination preparation.
Background technique
Cefotaxime is commonly called as ceftazidime, cephalo Ta Kaiding, the importer name of an article: fortum, Ceftazidime.This product be by
For O Callaghan et al. in discovery in 1978, nineteen eighty-three developed listing by Glaxo company of Britain first, is approved within 1985
U.S.'s sale is approved to sell in Japan, is formally included in essential drug list by China within 1993 for 1986.
Cefotaxime category third generation cephalosporin antibiotic, its main feature is that pseudomonas aeruginosa, Enterobacter, anaerobic bacteria, fragility
Bacillus etc. has bactericidal effect；Still there is larger antibacterial activity to various Gram-positives and negative bacterium simultaneously；, peace sufficiently stable to enzyme
Entirely, Small side effects and antimicrobial spectrum is extensive, thus be considered as the ideal replacement of aminoglycosides antibiotics.1985 by the U.S.
FDA is chosen as 1A grades of drugs.Cefotaxime is clinically suitable for negative bacillus infection, complicated operation or the pollution hand of state of an illness severe
The prevention of art is infected, and the severe infections etc. of each system of the person.
Synthesis in relation to cefotaxime, the document report different method of kind, (one) with 7-amino-cephalosporanic acid (7- amino
Cephalosporanic acid) it is starting parent nucleus, it is reacted under the action of Iodotrimethylsilane (TMSI) with pyridine, obtains 7- amino -3- (1- pyrrole
Pyridine methyl) cephemcarboxylic acid dihydrochloride, which reacts with ceftazidime side chain acid active ester, the cefotaxime tert-butyl ester is obtained,
The tert-butyl ester again through hydrolysis and etc. obtain 5 hydrate of cefotaxime.(2) with 7- phenyl acetamide -3- chloromethyl cephalosporin alkyl olefin(e) acid
It is to originate parent nucleus to obtain cefotaxime intermediate 7- phenylacetylamino -3- iodine with iodate nak response to methoxy benzyl ester (GCLE)
Methyl -3- cephalosporin-4-carboxyl acid carries out the series reactions such as nucleophilic displacement of fluorine and obtains to the end to methoxybenzyl ester, the intermediate and pyridine
His pyridine of spore.The cefotaxime of above two method preparation is 5 hydrates, and stability is poor, and thermal decomposition temperature is low.
Therefore, it is necessary to invent, a kind of preparation process is simple, high income, thermal stability are good, good fluidity, not easy to moisture absorption
Cefotaxime compound.
Summary of the invention
The first object of the present invention is to provide a kind of new cefotaxime solvate, is more specifically 51/4Head spore
His acridine compound, i.e., every mole of cefotaxime compound contain 51/4Mole water, molecular formula C22H22N6O7S2·51/4H2O, molecular weight 641.16, structural formula is as follows:
Of the present invention 51/4His acridine compound of head spore, preparation specific steps include:
(1) 7-amino-cephalosporanic acid, hexamethyldisilazane, trim,ethylchlorosilane are added to the methylene chloride of logical nitrogen
In, it flows back, N, N- diethylaniline is added in cooling, and Iodotrimethylsilane, temperature reaction is added in stirring, and cooling is slowly added to
Pyridine, temperature reaction, cooling are added Sodium Metabisulfite, are slowly added to methanol and hydrochloric acid solution, stir, stratification, separation
Acetone is added in water layer, and triethylamine is added and adjusts pH value, growing the grain stirring is filtered, washed, and vacuum drying obtains 7- amino -3- (1- pyrrole
Pyridine methyl) cephemcarboxylic acid；
(2) by Sodium Metabisulfite, tetrabutylammonium bromide addition methylene chloride, methanol mixed solution, 7- is added in temperature control
Triethylamine reaction, filtering, methylene chloride leaching is added in amino -3- (1- picolyl) cephemcarboxylic acid, cefotaxime pendant reactive ester
It is colourless to be washed till mother liquor, is dried in vacuo, obtains the cefotaxime tert-butyl ester；
(3) reduce temperature, to formic acid, concentrated hydrochloric acid mixed solution in, be added the cefotaxime tert-butyl ester, stir, heat up, protect
Temperature reaction, cooling are slowly added to acetone, stir, active carbon decoloring, filtering, and filtrate heating is slowly added to acetone, cools down, supports
Crystalline substance filters, and washs, and vacuum drying obtains cefotaxime dihydrochloride；
(4) cefotaxime dihydrochloride is dissolved in ice water, active carbon decoloring, is filtered, heating is slowly stirred, and hydrogen is added
Sodium hydroxide solution adjusts pH value, adds appropriate crystal seed, and first acid for adjusting pH value reduces temperature, growing the grain, and filtering is washed with cold water and acetone
It washs, is dried in vacuo, be made 51/4His acridine compound of head spore.
In above-mentioned preparation method, reduction temperature described in step (1) to -5 DEG C~2 DEG C, it is described be warming up to 10 DEG C~
15 DEG C, the adjusting pH value to 2.8~3.0.
In above-mentioned preparation method, Sodium Metabisulfite described in step (2), tetrabutylammonium bromide and cefotaxime side chain
The molar ratio of active ester is 1:0.6:52, and the volume ratio of the methylene chloride and methanol is 10:1, and the temperature control is 5
DEG C~10 DEG C.
In above-mentioned preparation method, reduction temperature described in step (3) is 0 DEG C~5 DEG C, the formic acid and concentrated hydrochloric acid
Volume ratio is 3:2, and described is warming up to 15 DEG C~20 DEG C, and the insulation reaction time is 2~4h, and the rearing crystal time is
0.5~1h.
In above-mentioned preparation method, raising temperature described in step (4) is described to be adjusted with sodium hydroxide to 20-25 DEG C
PH value is to 4.3~4.7, and the use first acid for adjusting pH value to 3.4~3.8, the reduction temperature is to 0 DEG C~5 DEG C.
Karl_Fischer method be containing one of the most single-minded, accurate method in moisture method in various measurement substances, by
It is classified as the basic skills of determination of moisture in many substances, especially to organic compound, as a result accurately and reliably.It is disclosed by the invention
Cefotaxime compound Karl_Fischer method measures moisture content between 14.45%~15.04%, and theoretical moisture content is
14.76%, it may be determined that cefotaxime compound of the present invention contains 51/4Water.
Of the present invention 51/4His acridine compound of head spore, TG are analyzed the results show that according to the percentage loss of weight of TG line
Calculated result is it is found that weightlessness about 14.95%, and the theoretical percentage composition of water is 14.76% in cefotaxime molecule, referring to taking Xiu Shi
It is 14.45~15.04% that method, which measures cefotaxime moisture content, and it is 14.95% that experiment, which measures TG weightlessness, with theoretical water content
Substantially it is consistent.It can be inferred that cefotaxime TG weightlessness is caused by removing water, and every mole of cefotaxime contains 51/4Mole of water.Such as
Shown in attached drawing 1.Data are obtained by heat analysis-mass spectrometer (NETZSCH STA 449C) analysis.Analysis condition are as follows: sample 2
~10mg, alumina crucible, high pure nitrogen do reaction gas and protection gas, and flow is respectively 40ml/min and 30ml/min, heating
Rate 10K/min, temperature test range are 25~400 DEG C.Sample decomposition temperature is about 188.9 DEG C.
Of the present invention 51/4His acridine compound of head spore, infrared spectroscopy are 3402.3 ± 2cm in wave number-1,
1770.6±2cm-1, 1618.2 ± 2cm-1, 1535.4 ± 2cm-1, 1396.5 ± 2cm-1, 1363.7 ± 2cm-1, 1156.7 ±
2cm-1, 984.5 ± 2cm-1, 966.3 ± 2cm-1, 918.6 ± 2cm-1There is characteristic absorption peak at place, as shown in Fig. 2.Infrared spectroscopy
Test condition are as follows: Agilent Cary630, pressing potassium bromide troche.
Of the present invention 51/4His acridine compound of head spore, x-ray diffractogram of powder spectrum 2 θ of the angle of diffraction be 8.85 ±
0.2 °, 10.12 ± 0.2 °, 14.82 ± 0.2 °, 16.29 ± 0.2 °, 17.09 ± 0.2 °, 18.75 ± 0.2 °, 21.57 ± 0.2 °,
There is characteristic diffraction peak at 24.15 ± 0.2 °, the opposite diffracted intensity of the angle of diffraction is respectively 100,59.48,56.48,36.55,
34.21,69.19,57.87,60.25.As shown in Fig. 3.X-ray powder diffraction test condition: Dutch Panalytical company
EMPYREAN (sharp shadow) X-ray diffractometer, CuK α radiation, light pipe voltage 40kV, heater current 300mA, continuous scanning, step-length
0.02 °, 8 °/min of scanning speed, scanning range is 2~50 °.
Of the present invention 51/4His acridine compound of head spore, dsc analysis the results show that have endothermic peak at about 78.2 DEG C,
There is exothermic peak in about 194.4 DEG C and 256.9 DEG C.As shown in Fig. 4.DSC data is by heat analysis-mass spectrometer (NETZSCH
STA449C) analysis obtains, analysis condition are as follows: and 2~10mg of sample, alumina crucible, high pure nitrogen do reaction gas and protection gas,
Flow is respectively 40ml/min and 30ml/min.10 DEG C/min of heating rate, 25~400 DEG C of temperature range.
Provided by the invention 51/4His acridine compound thermal stability of head spore is good, and dsc analysis shows that it has suction at about 78.2 DEG C
Thermal spike has exothermic peak in about 194.4 DEG C and 256.9 DEG C.Accelerated stability test shows of the invention 51/4Water cefotaxime chemical combination
The stability of object is better than ceftazidime pentahydrate.Provided by the invention 51/4His acridine compound of head spore and five water of cefotaxime
Object is closed compared to less easy to moisture absorption.Therefore provided by the invention 51/4Head spore he acridine compound be better than in terms of stability, moisture resistance
Ceftazidime pentahydrate has wider application prospect.
Further purpose of the invention provides a kind of containing 51/4The pharmaceutical composition of his acridine compound of head spore.It is preferred that
Ground, described pharmaceutical composition include 51/4His acridine compound of head spore and the excipient pharmaceutically received.It is highly preferred that medicine group
It closes object and is selected from pharmaceutically acceptable dosage form.
Detailed description of the invention
Fig. 1 is 51/4The TG analysis chart of his acridine compound of head spore.
Fig. 2 is 51/4The FTIR spectrum figure of his acridine compound of head spore.
Fig. 3 is 51/4The X ray diffracting spectrum of his acridine compound of head spore.
Fig. 4 is 51/4The dsc analysis figure of his acridine compound of head spore.
Specific embodiment
Below will by specific embodiment, the present invention will be further described, but therefore do not limit the present invention to institute
In the scope of embodiments stated, it should be understood by those skilled in the art that changing to the equivalent replacement that the content of present invention is done, or accordingly
Into still falling within protection scope of the present invention.
Embodiment 1:51/4The preparation of his acridine compound of head spore
(1) 5L is added in 400g 7-amino-cephalosporanic acid, 480ml hexamethyldisilazane, 1ml trim,ethylchlorosilane to lead to
In the methylene chloride of nitrogen, flow back 10h, is cooled to 0 DEG C, and 400mlN is added, and N- diethylaniline stirs 30min, is added
360ml Iodotrimethylsilane is warming up to 10 DEG C of reaction 3h, is cooled to -5 DEG C, is slowly added to 400ml pyridine, is warming up to 10 DEG C instead
2h is answered, is cooled to 2 DEG C, 6g Sodium Metabisulfite is added, is slowly added to 40ml methanol and the hydrochloric acid solution of 50ml2mol/L, is stirred
20min, stratification separate water layer, and 1L acetone is added, and triethylamine is added and adjusts pH value to 2.8, growing the grain stirs 1h, and filtering is washed
It washs, is dried in vacuo, obtains 7- amino -3- (1- picolyl) cephemcarboxylic acid 427g；
(2) 1.5L methylene chloride, 150ml methanol mixed solution is added in 2g Sodium Metabisulfite, 2g tetrabutylammonium bromide
In, controlled at 10 DEG C, 200g7- amino -3- (1- picolyl) cephemcarboxylic acid, 300g cefotaxime pendant reactive is added
Ester is added 150ml triethylamine and reacts 12h, and filtering, eluent methylene chloride is colourless to mother liquor, and vacuum drying obtains 286g cefotaxime
The tert-butyl ester；
(3) reduce temperature to 0 DEG C, to 180ml formic acid, 120ml concentrated hydrochloric acid mixed solution in, be added 200g cefotaxime
The tert-butyl ester, stirring, is warming up to 15 DEG C, and insulation reaction 3h is cooled to 0 DEG C, is slowly added to 80ml acetone, stirs, active carbon decoloring,
Filtering, filtrate are warming up to 15 DEG C, are slowly added to 2L acetone, cool down, and growing the grain filters, and wash, and vacuum drying obtains cefotaxime two
Hydrochloride 169g；
(4) 160g cefotaxime dihydrochloride is dissolved in ice water, active carbon decoloring, filters, is warming up to 20 DEG C, slowly stirs
It mixes, sodium hydroxide solution is added, adjust pH value to 4.3, add appropriate crystal seed, first acid for adjusting pH value to 3.4 reduces temperature to 0 DEG C, supports
Crystalline substance, filtering, with cold water and acetone washing, 40 DEG C of vacuum drying 30min are made 51/4His acridine compound 119g of head spore.
X-ray powder diffraction pattern 2 θ of the angle of diffraction be 8.85 °, 10.12 °, 14.82 °, 16.29 °, 17.09 °,
There is characteristic diffraction peak at 18.75 °, 21.57 °, 24.15 °, the opposite diffracted intensity of the angle of diffraction is respectively 100,59.48,56.48,
36.55,34.21,69.19,57.87,60.25.
FTIR spectrum diagram data is as follows:
| Serial number | Wave number | Area |
| 1 | 3402.338 | 526.176 |
| 2 | 1770.569 | 1524.545 |
| 3 | 1618.198 | 733.032 |
| 4 | 1535.383 | 377.641 |
| 5 | 1396.454 | 262.928 |
| 6 | 1363.654 | 187.983 |
| 7 | 1156.744 | 351.215 |
| 8 | 984.513 | 62.560 |
| 9 | 966.250 | 108.177 |
It is 99.09% that HPLC method, which detects purity,；It is 14.90% that Karl_Fischer method, which measures moisture, and thermogravimetric analysis weightlessness is
14.86%, in this way with contain 51/4The result (theoretical value 14.76%) of a water is almost the same；Elemental Analysis theory are as follows: C:
41.21%, H:5.11%, N:13.11%, O:30.57%, S:10.00%；Measured value are as follows: C:41.30%, H:5.15%, N:
13.08%, O:30.48%, S:9.99%.
Embodiment 2:51/4The preparation of his acridine compound of head spore
(1) 50L is added in 4kg 7-amino-cephalosporanic acid, 5L hexamethyldisilazane, 10ml trim,ethylchlorosilane and leads to nitrogen
In the methylene chloride of gas, flow back 10h, is cooled to -5 DEG C, and 4LN is added, and N- diethylaniline stirs 30min, and 3.6L front three is added
Base iodine silane is warming up to 15 DEG C of reaction 3h, is cooled to 0 DEG C, is slowly added to 4L pyridine, is warming up to 15 DEG C of reaction 2h, is cooled to 0
DEG C, 60g Sodium Metabisulfite is added, is slowly added to 400ml methanol and the hydrochloric acid solution of 500ml2mol/L, stirs 20min, it is quiet
Layering is set, water layer is separated, 10L acetone is added, triethylamine is added and adjusts pH value to 3.0, growing the grain stirs 1h, filters, washing, vacuum
It is dry, obtain 7- amino -3- (1- picolyl) cephemcarboxylic acid 4.75kg；
(2) 30L methylene chloride is added, in 3L methanol mixed solution in 40g Sodium Metabisulfite, 40g tetrabutylammonium bromide,
Controlled at 5 DEG C, 4kg7- amino -3- (1- picolyl) cephemcarboxylic acid, 6kg cefotaxime pendant reactive ester is added, is added
30L triethylamine reacts 12h, and filtering, eluent methylene chloride is colourless to mother liquor, and vacuum drying obtains the 5.66Kg cefotaxime tert-butyl ester；
(3) reduce temperature to 5 DEG C, to 3.6L formic acid, 2.4L concentrated hydrochloric acid mixed solution in, be added 4Kg cefotaxime uncle
Butyl ester, stirring, is warming up to 20 DEG C, and insulation reaction 3h is cooled to 5 DEG C, is slowly added to 1.6L acetone, stirs, active carbon decoloring, mistake
Filter, filtrate are warming up to 20 DEG C, are slowly added to 40L acetone, cool down, and growing the grain filters, and wash, and vacuum drying obtains cefotaxime disalt
Hydrochlorate 3.54kg；
(4) 3.2kg cefotaxime dihydrochloride is dissolved in ice water, active carbon decoloring, filters, is warming up to 25 DEG C, slowly
Sodium hydroxide solution is added in stirring, adjusts pH value to 4.7, adds appropriate crystal seed, first acid for adjusting pH value to 3.8, reduces temperature to 5 DEG C,
Growing the grain, filtering, with cold water and acetone washing, 40 DEG C of vacuum drying 30min are made 51/4His acridine compound 2.41kg of head spore.
X-ray powder diffraction pattern 2 θ of the angle of diffraction be 8.88 °, 10.10 °, 14.86 °, 16.31 °, 17.12 °,
There is characteristic diffraction peak at 18.77 °, 21.62 °, 24.23 °, the opposite diffracted intensity of the angle of diffraction is respectively 100,59.66,57.85,
38.26,35.71,68.49,58.20,61.35.
FTIR spectrum diagram data is as follows:
| Serial number | Wave number | Area |
| 1 | 3402.154 | 525.877 |
| 2 | 1770.317 | 1524.479 |
| 3 | 1618.025 | 733.422 |
| 4 | 1535.401 | 377.526 |
| 5 | 1396.177 | 262.751 |
| 6 | 1363.419 | 187.827 |
| 7 | 1156.518 | 350.907 |
| 8 | 984.402 | 62.389 |
| 9 | 966.513 | 108.052 |
It is 99.13% that HPLC method, which detects purity,；It is 14.45% that Karl_Fischer method, which measures moisture, and thermogravimetric analysis weightlessness is
14.78%, in this way with contain 51/4The result (theoretical value 14.76%) of a water is almost the same；Elemental Analysis theory are as follows: C:
41.21%, H:5.11%, N:13.11%, O:30.57%, S:10.00%；Measured value are as follows: C:41.27%, H:5.10%, N:
13.05%, O:30.60%, S:9.98%.
Embodiment 351/4The preparation (1.0g specification) of his acridine compound pharmaceutical composition of head spore
Prescription:
| 51/4His acridine compound of head spore | 1000g |
| Natrium carbonicum calcinatum | 118g |
| It is made | 1000 bottles |
By the 5 of recipe quantity1/4His acridine compound of head spore and natrium carbonicum calcinatum are placed in mixing machine and mix 30~60 minutes,
To uniformly mixed, filling, tamponade, Zha Gai.
Embodiment 451/4The preparation (1.0g specification) of his acridine compound pharmaceutical composition of head spore
Prescription:
| 51/4His acridine compound of head spore | 1000g |
| Arginine | 320g |
| It is made | 1000 bottles |
By the 5 of recipe quantity1/4His acridine compound of head spore and arginine are placed in mixing machine and mix 30~60 minutes, until mixed
Close uniformly filling, tamponade, Zha Gai.
Comparative example 1: ceftazidime pentahydrate is prepared using the method for embodiment 1 in patent of invention CN101607966A
It is specific the preparation method is as follows:
Step 1: injecting water for injection 30ml into dissolving tank, cefotaxime hydrochloride 18g is added, after dissolution, investment is lived
Property charcoal 0.5g, decolourize 30 minutes, filtering, filtrate is stand-by；
Step 2: injecting water for injection 45ml into another dissolving tank, cefotaxime hydrochloride 25g is added, after dissolution,
Active carbon 0.5g is put into, is decolourized 30 minutes, filtering, filtrate is transferred to crystallizing tank；
Step 3: it is 3N sodium hydroxide solution that equivalent concentration is added dropwise in crystallizing tank into second step, adjust pH to 4.8, then
The filtrate being added dropwise in the first step makes pH value pull back to 3.6, is kept for 0-10 DEG C of temperature, stirs, crystallization；
Step 4: growing the grain filters after 3-4 hours, filter cake cold water and acetone are respectively washed twice, are dried in vacuo 2-3 hours, are obtained
To ceftazidime pentahydrate crystal 15.03g.
The theoretical percentage composition of water is 14.18% in ceftazidime pentahydrate molecule, by TG line analysis as a result, weightlessness
Percentage about 14.26%, it is 14.20% that Karl_Fischer method, which detects cefotaxime compound moisture content prepared by comparative example 1,
There is no notable difference with theoretical value 14.18%, it was demonstrated that cefotaxime compound prepared by comparative example 1 contains 5 water.
It is 98.72% that HPLC method, which detects purity,；Elemental Analysis theory are as follows: C:41.51%, H:5.07%, N:
13.20%, O:30.16%, S:10.07%；Measured value are as follows: C:41.53%, H:5.05%, N:13.23%, O:30.15%,
S:10.05%.
1 study on the stability of test example
The present inventor has carried out accelerated stability to cefotaxime prepared by the embodiment of the present invention 1~2 and comparative example 1 and has examined
Examine test.Investigation condition is 40 DEG C ± 2 DEG C of temperature, is placed 6 months, is sampled respectively at 0,1,2,3,6 the end of month.Inspection target is property
Shape, clarity, solution colour, moisture, pH value, content and related substance.
Test example 2 draws moist investigation
Prepared by the embodiment of the present invention 1~2 51/4The cephalo of head spore his acridine compound and comparative example 1 of the present invention preparation
His pyridine pentahydrate is placed in dynamic vapor sorption instrument under the conditions of 40 DEG C, and the weight change in record three hours, test result is such as
Under:
| Relative humidity RH/% | Embodiment 1 | Embodiment 2 | Comparative example 1 |
| 0 | 0 | 0 | 0 |
| 10 | 0 | 0 | 0 |
| 20 | 0.02 | 0.01 | 0.06 |
| 30 | 0.02 | 0.01 | 0.07 |
| 40 | 0.02 | 0.02 | 0.07 |
| 50 | 0.17 | 0.09 | 0.62 |
| 60 | 0.33 | 0.20 | 0.69 |
| 70 | 0.58 | 0.41 | 1.32 |
Conclusion: provided by the invention 51/4His acridine compound of head spore is less easy to moisture absorption compared with ceftazidime pentahydrate.
3 mobility of test example is investigated
The present inventor takes funnel method to survey cefotaxime compound prepared by the embodiment of the present invention 1~2 and comparative example 1
Determine angle of repose, the mobility of cefotaxime is studied.Angle of repose testing result:
Angle of repose testing result:
| Embodiment | Angle of repose θ |
| Embodiment 1 | 27.3° |
| Embodiment 2 | 28.7° |
| Comparative example 1 | 35.2° |
Conclusion: prepared by the present invention 51/4The mobility of his acridine compound of head spore is apparently higher than the cephalo of the preparation of comparative example 1
His acridine compound can satisfy the needs of different preparations preparations.
4 dissolubility of test example is investigated
Cefotaxime prepared by Examples 1 to 2 and comparative example 1 is dissolved in aqueous solution respectively, 20min is shaked, passes through
Detection level calculates the solubility of cefotaxime compound in water prepared by Examples 1 to 2, comparative example 1.
Solubility testing result
| Embodiment | Solubility |
| Embodiment 1 | 6.8mg/ml |
| Embodiment 2 | 7.4mg/ml |
| Comparative example 1 | 3.9mg/ml |
Conclusion: the 5 of the preparation of the embodiment of the present invention 1~21/4The dissolubility of his acridine compound of head spore is significantly better than comparative example 1
Cefotaxime compound.
The verifying of 5 crystallization water of test example is investigated
In order to sufficiently verify 5 in cefotaxime compound of the present invention1/4Water is the crystallization water, and the present inventor passes through thermogravimetric point
Three kinds of analysis method, 60 DEG C of thermal stability 10 days, vacuum freezedrying weight-loss method methods, investigate the moisture knot of each embodiment and comparative example
Fruit, specific as follows:
1, thermogravimetry
Thermogravimetric analysis is the weightlessness before sample decomposes at high operating temperatures, is the important side for verifying the crystallization water or adsorbing water
Method, the present inventor have carried out thermogravimetric analysis to the cefotaxime compound of each embodiment and comparative example preparation respectively, have as a result summarized
It is as follows:
| Embodiment | Thermogravimetry weightlessness (%) |
| Embodiment 1 | 14.95 |
| Embodiment 2 | 14.78 |
| Comparative example 1 | 14.26 |
As a result, the 5 of Examples 1 to 2 preparation1/4His acridine compound weightlessness of head spore with contain 51/4Result (the reason of a water
By value 14.76%) it is almost the same；Result (the reason of ceftazidime pentahydrate weightlessness prepared by comparative example 1 and 5 water contained
By value 14.18%) it is almost the same.The cefotaxime compound institute for inferring prepared by the embodiment of the present invention 1~2 and comparative example 1 is aqueous
For crystallization water water.
2,60 DEG C thermal stability 10 days
By the 5 of preparation of the embodiment of the present invention1/4The five water object of cefotaxime of head spore his acridine compound and the preparation of comparative example 1
It is respectively placed in 60 DEG C of baking ovens 10 days, detected moisture with Karl_Fischer method respectively at 0,10 day, as a result as follows:
| Embodiment | 0 day (%) | 10 days (%) |
| Embodiment 1 | 14.90 | 14.89 |
| Embodiment 2 | 14.45 | 14.41 |
| Comparative example 1 | 14.20 | 14.02 |
As a result, 60 DEG C of high temperature are placed 10 days, the 5 of Examples 1 to 2 preparation1/4His acridine compound of head spore and comparative example 1 are made
Standby five water object moisture of cefotaxime infers head prepared by the embodiment of the present invention 1~2 and comparative example 1 substantially without significant change
Aqueous his acridine compound institute of spore is the crystallization water.
3, vacuum freezedrying 10 hours
By the 5 of preparation of the embodiment of the present invention1/4The five water object of cefotaxime of head spore his acridine compound and the preparation of comparative example 1
It is respectively placed in -45 DEG C of freeze driers and vacuumizes 10 hours, detected moisture with Karl_Fischer method respectively at 0,10 hour, as a result
It is as follows:
| Embodiment | 0 hour (%) | 10 hours (%) |
| Embodiment 1 | 14.90 | 14.87 |
| Embodiment 2 | 14.45 | 14.41 |
| Comparative example 1 | 14.20 | 13.96 |
As a result, -45 DEG C of vacuum freezedryings of low temperature 10 hours, the 5 of Examples 1 to 2 preparation1/4His acridine compound of head spore
The five water object moisture of cefotaxime prepared with comparative example 1 without significant change, infers the embodiment of the present invention 1~2 and comparison substantially
Aqueous cefotaxime compound institute prepared by example 1 is the crystallization water.
Claims (4)
1. a kind of drug combination preparation, it is characterised in that containing one kind 51/4His acridine compound of head spore, this every mole cefotaxime
Compound contains 51/4Mole of water, molecular formula C22H22N6O7S2·51/4H2O, molecular weight 641.16, structural formula is as follows:
2. one kind 51/4His acridine compound of head spore, which is characterized in that every mole of cefotaxime compound contains 51/4Mole of water, molecule
Formula is C22H22N6O7S2·51/4H2O, molecular weight 641.16, structural formula is as follows:
3. a kind of drug combination preparation, it is characterised in that include described in claim 151/4His acridine compound of head spore and medicine
The excipient received on.
4. pharmaceutical composition according to claim 3, it is characterised in that described pharmaceutical composition is selected from pharmaceutically acceptable
Dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710477794.4A CN109111467A (en) | 2017-06-22 | 2017-06-22 | One kind 51/4His acridine compound of head spore and its drug combination preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710477794.4A CN109111467A (en) | 2017-06-22 | 2017-06-22 | One kind 51/4His acridine compound of head spore and its drug combination preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109111467A true CN109111467A (en) | 2019-01-01 |
Family
ID=64732079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710477794.4A Pending CN109111467A (en) | 2017-06-22 | 2017-06-22 | One kind 51/4His acridine compound of head spore and its drug combination preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109111467A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109096309A (en) * | 2017-06-20 | 2018-12-28 | 王秀香 | One kind 43/4His acridine compound of head spore and its pharmaceutical composition |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
| CN101607966A (en) * | 2008-06-19 | 2009-12-23 | 上海新先锋药业有限公司 | The preparation method of ceftazidime pentahydrate |
| CN102286003A (en) * | 2011-08-05 | 2011-12-21 | 哈药集团制药总厂 | Synthesis method of ceftazidime |
| CN102391289A (en) * | 2011-12-03 | 2012-03-28 | 齐鲁安替制药有限公司 | Synthetic methods of ceftazidime intermediate and ceftazidime |
| CN105646541A (en) * | 2015-12-30 | 2016-06-08 | 中山市金城道勃法制药有限公司 | Original development quality ceftazidime and medicine preparation thereof |
| CN106279208A (en) * | 2016-08-15 | 2017-01-04 | 陕西顿斯制药有限公司 | A kind of cefotaxime sodium compound utilizing fluid mechanics principle to prepare and preparation thereof |
| CN106432273A (en) * | 2016-09-07 | 2017-02-22 | 陕西顿斯制药有限公司 | Cefoperazone sodium compound prepared by using fluid mechanics principle and preparation comprising cefoperazone sodium compound |
| CN106432269A (en) * | 2016-09-07 | 2017-02-22 | 陕西顿斯制药有限公司 | Cefradine compound prepared by adopting high-flux medicine crystal form rapid screening technology and preparation thereof |
| CN109096309A (en) * | 2017-06-20 | 2018-12-28 | 王秀香 | One kind 43/4His acridine compound of head spore and its pharmaceutical composition |
| CN109134500A (en) * | 2017-07-19 | 2019-01-04 | 郝志艳 | A kind of 1/2 water cefradine compound |
| CN109134506A (en) * | 2017-07-19 | 2019-01-04 | 宁应 | One water cefotiam hydrochloride compound of one kind and its pharmaceutical composition |
-
2017
- 2017-06-22 CN CN201710477794.4A patent/CN109111467A/en active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
| CN101607966A (en) * | 2008-06-19 | 2009-12-23 | 上海新先锋药业有限公司 | The preparation method of ceftazidime pentahydrate |
| CN102286003A (en) * | 2011-08-05 | 2011-12-21 | 哈药集团制药总厂 | Synthesis method of ceftazidime |
| CN102391289A (en) * | 2011-12-03 | 2012-03-28 | 齐鲁安替制药有限公司 | Synthetic methods of ceftazidime intermediate and ceftazidime |
| CN105646541A (en) * | 2015-12-30 | 2016-06-08 | 中山市金城道勃法制药有限公司 | Original development quality ceftazidime and medicine preparation thereof |
| CN106279208A (en) * | 2016-08-15 | 2017-01-04 | 陕西顿斯制药有限公司 | A kind of cefotaxime sodium compound utilizing fluid mechanics principle to prepare and preparation thereof |
| CN106432273A (en) * | 2016-09-07 | 2017-02-22 | 陕西顿斯制药有限公司 | Cefoperazone sodium compound prepared by using fluid mechanics principle and preparation comprising cefoperazone sodium compound |
| CN106432269A (en) * | 2016-09-07 | 2017-02-22 | 陕西顿斯制药有限公司 | Cefradine compound prepared by adopting high-flux medicine crystal form rapid screening technology and preparation thereof |
| CN109096309A (en) * | 2017-06-20 | 2018-12-28 | 王秀香 | One kind 43/4His acridine compound of head spore and its pharmaceutical composition |
| CN109134500A (en) * | 2017-07-19 | 2019-01-04 | 郝志艳 | A kind of 1/2 water cefradine compound |
| CN109134506A (en) * | 2017-07-19 | 2019-01-04 | 宁应 | One water cefotiam hydrochloride compound of one kind and its pharmaceutical composition |
Non-Patent Citations (1)
| Title |
|---|
| 郑玉林: "头孢他啶的合成工艺改进", 《中国药物化学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109096309A (en) * | 2017-06-20 | 2018-12-28 | 王秀香 | One kind 43/4His acridine compound of head spore and its pharmaceutical composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101584665B (en) | Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof | |
| CN102180889A (en) | Ceftizoxime sodium crystalline hydrate and preparation method and application thereof | |
| CN109134503B (en) | Quadrature conidium compound | |
| CN109160923A (en) | A kind of 1/4 water Cefobutazine sodium compound | |
| CN106699775B (en) | 1/5 water Cefamandole nafate compounds | |
| CN103524532B (en) | Ceftizoxime sodium compound crystal form, and preparing method and pharmaceutical preparation thereof | |
| CN106831821B (en) | 1/4 water Cefamandole nafate compounds | |
| CN109134506A (en) | One water cefotiam hydrochloride compound of one kind and its pharmaceutical composition | |
| CN109134502A (en) | A kind of 1/2 water cefuroxime sodium compound | |
| CN106279208A (en) | A kind of cefotaxime sodium compound utilizing fluid mechanics principle to prepare and preparation thereof | |
| CN109096304A (en) | A kind of 3/4 water cefuroxime sodium compound | |
| CN109134500A (en) | A kind of 1/2 water cefradine compound | |
| CN109096309B (en) | One kind 43/4His acridine compound of head spore and its pharmaceutical composition | |
| CN109111467A (en) | One kind 51/4His acridine compound of head spore and its drug combination preparation | |
| CN106432273A (en) | Cefoperazone sodium compound prepared by using fluid mechanics principle and preparation comprising cefoperazone sodium compound | |
| CN109160922A (en) | A kind of 1/2 water Cefobutazine sodium compound | |
| CN109134501A (en) | 1/5 water cefradine compound of one kind and its drug combination preparation | |
| CN109096306A (en) | A kind of 1/2 water Cefazolin sodium compound | |
| CN104072519A (en) | Cefuroxime sodium compound entity and application thereof | |
| CN109160919A (en) | 1/10 water sulbactam sodium compound of one kind and its drug combination preparation | |
| CN109096308A (en) | 1/4 water cefmenoxime hydrochloride compound of one kind and its pharmaceutical composition | |
| CN109096310A (en) | A kind of 1/4 water Cefoxitin sodium compound | |
| CN109081847A (en) | A kind of 1/2 water cefotaxime sodium compound | |
| CN109160924A (en) | Two water cefotiam hydrochloride compounds of one kind and its drug combination preparation | |
| CN109134504A (en) | 1/2 water cefmenoxime hydrochloride compound of one kind and its drug combination preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20190809 Address after: 710399 Standardized Workshop Phase I Construction Zone of Fengjing Industrial Park, Xi'an City, Shaanxi Province Applicant after: SHAANXI DUNSI PHARMACEUTICAL CO.,LTD. Applicant after: Yining Elxing Intellectual Property Service Co.,Ltd. Address before: 250101 Lixia District, Jinan City, Shandong Province, No. 66 Lin Road, 8-1-803, Zhonghai Ziyudong County Applicant before: Ning Ying |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190101 |